This is what I believe will happen after the FDA accepts the NDA from AVEO. The stock is being artificially held past Reverse Split. There is no reason, after the threat of delisting was eliminated, to be trading below $1.00 pre RS price ($10.00 now) . This algorithm has held this stock down and every spike was shorted to where we are today. Once volume comes back retail holders will be tempted to sell their positions but they should fight this urge. MIchael Bailey's timely delays and Press Releases should not be overlooked as he might have been an accomplice to those profiting from the short sold positions.